Mitragynine alkaloids as opioid receptor modulators

The present invention provides a compound having the structure:or a pharmaceutically acceptable salt or ester thereof, and a method of treating a subject afflicted with pain, a depressive disorder, a mood disorder or an anxiety disorder by administering the compound to the subject.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Sames, Dalibor, Wulf, Madalee G, Javitch, Jonathan A, Kruegel, Andrew
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Sames, Dalibor
Wulf, Madalee G
Javitch, Jonathan A
Kruegel, Andrew
description The present invention provides a compound having the structure:or a pharmaceutically acceptable salt or ester thereof, and a method of treating a subject afflicted with pain, a depressive disorder, a mood disorder or an anxiety disorder by administering the compound to the subject.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US10961244B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US10961244B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US10961244B23</originalsourceid><addsrcrecordid>eNrjZDD2zSwpSkyvzMvMS1VIzMlOzMnPTClWSCxWyC_IBDIVilKTUwtK8osUcvNTSnMSgaxiHgbWtMSc4lReKM3NoOjmGuLsoZtakB-fWlyQmJyal1oSHxpsaGBpZmhkYuJkZEyMGgA_ZS0l</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Mitragynine alkaloids as opioid receptor modulators</title><source>esp@cenet</source><creator>Sames, Dalibor ; Wulf, Madalee G ; Javitch, Jonathan A ; Kruegel, Andrew</creator><creatorcontrib>Sames, Dalibor ; Wulf, Madalee G ; Javitch, Jonathan A ; Kruegel, Andrew</creatorcontrib><description>The present invention provides a compound having the structure:or a pharmaceutically acceptable salt or ester thereof, and a method of treating a subject afflicted with pain, a depressive disorder, a mood disorder or an anxiety disorder by administering the compound to the subject.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20210330&amp;DB=EPODOC&amp;CC=US&amp;NR=10961244B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20210330&amp;DB=EPODOC&amp;CC=US&amp;NR=10961244B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Sames, Dalibor</creatorcontrib><creatorcontrib>Wulf, Madalee G</creatorcontrib><creatorcontrib>Javitch, Jonathan A</creatorcontrib><creatorcontrib>Kruegel, Andrew</creatorcontrib><title>Mitragynine alkaloids as opioid receptor modulators</title><description>The present invention provides a compound having the structure:or a pharmaceutically acceptable salt or ester thereof, and a method of treating a subject afflicted with pain, a depressive disorder, a mood disorder or an anxiety disorder by administering the compound to the subject.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDD2zSwpSkyvzMvMS1VIzMlOzMnPTClWSCxWyC_IBDIVilKTUwtK8osUcvNTSnMSgaxiHgbWtMSc4lReKM3NoOjmGuLsoZtakB-fWlyQmJyal1oSHxpsaGBpZmhkYuJkZEyMGgA_ZS0l</recordid><startdate>20210330</startdate><enddate>20210330</enddate><creator>Sames, Dalibor</creator><creator>Wulf, Madalee G</creator><creator>Javitch, Jonathan A</creator><creator>Kruegel, Andrew</creator><scope>EVB</scope></search><sort><creationdate>20210330</creationdate><title>Mitragynine alkaloids as opioid receptor modulators</title><author>Sames, Dalibor ; Wulf, Madalee G ; Javitch, Jonathan A ; Kruegel, Andrew</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US10961244B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2021</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Sames, Dalibor</creatorcontrib><creatorcontrib>Wulf, Madalee G</creatorcontrib><creatorcontrib>Javitch, Jonathan A</creatorcontrib><creatorcontrib>Kruegel, Andrew</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Sames, Dalibor</au><au>Wulf, Madalee G</au><au>Javitch, Jonathan A</au><au>Kruegel, Andrew</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Mitragynine alkaloids as opioid receptor modulators</title><date>2021-03-30</date><risdate>2021</risdate><abstract>The present invention provides a compound having the structure:or a pharmaceutically acceptable salt or ester thereof, and a method of treating a subject afflicted with pain, a depressive disorder, a mood disorder or an anxiety disorder by administering the compound to the subject.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US10961244B2
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Mitragynine alkaloids as opioid receptor modulators
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-18T22%3A00%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Sames,%20Dalibor&rft.date=2021-03-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS10961244B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true